Annual Report to the Nation on the Status of Cancer, 1975–2012, Featuring the Increasing Incidence of Liver Cancer
By A. B. Ryerson, C. Eheman, S. Altekruse, J. W. Ward, A. Jemal, Recinda L. Sherman, S. Henley, D. Holtzman, Andrew J. Lake, A. Noone and 6 more. Cancer, 2016
923 citations recorded by the source corpus.
Annual updates on cancer occurrence and trends in the United States are provided through an ongoing collaboration among the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR). This annual report highlights the increasing burden of liver and intrahepatic bile duct (liver) cancers.
Subfields: Economics and Econometrics, Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/7f6d3e661e6448d14dc901268b1fead9e2573183
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
In Epidemiology
In Oncology
- A. Jemal
- R. Siegel
- Jiemin Ma
- Elizabeth E. Ward
- Lindsey A. Torre
- Birgit Schoeberl
- A. Mariotto
- K. Miller
Citations in the corpus
- Global Cancer in Women: Burden and Trends (2017, background): “Other major risk factors for hepatocellular carcinoma include heavy alcohol drinking, excess body weight, type II diabetes, nonalcoholic fatty liver disease, smoking, and exposure to a fl a-toxins (77, 156, 157).”
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics (2018, background): “This article has been contributed to by US Government employees, and their work is in the public domain in the United States.”
- Predicting ligand-dependent tumors from multi-dimensional signaling features (2017, background): “The research to understand and therapeutically battle various cancer types has made significant progress over the last two decades, decreasing the overall mortality by roughly 2% per year since 2001.(58) Targeted therapy and combinations thereof have become important areas of drug development with r”
- Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival (2017, background): “In contrast, the continued increase in liver cancer incidence rates is likely due to the high prevalence of chronic hepatitis C virus infection resulting from intravenous drug use by baby boomers during the 1960s to 1980s, as well as the obesity epidemic beginning in the 1980s (18).”
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level (2017, neutral): “amongadults bornbetween 1945 and 1965 associatedwith injection drug use and transfusion of unsafe blood products.(9)”